Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosolized medications for altering lung surface active properties.

N R MacIntyre1

  • 1Respiratory Care Services, Duke University Medical Center, Durham, North Carolina 27710, USA. macin001@mc.duke.edu

Respiratory Care
|July 14, 2000
PubMed
Summary

Surface active material is crucial for infant and adult lung function. Aerosol delivery shows promise for treating respiratory distress syndrome (RDS) and acute respiratory distress syndrome (ARDS) by improving surfactant replacement strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus statement: aerosols and delivery devices.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same author

Treatment of forearm fractures.

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2009
Same author

High-frequency ventilation.

Seminars in respiratory and critical care medicine·2005
Same author

Tracheal gas insufflation.

Seminars in respiratory and critical care medicine·2005
Same author

Mechanical ventilation strategies for lung protection.

Seminars in respiratory and critical care medicine·2005
Same author

Advances in infection control: ventilator-associated pneumonia.

Seminars in respiratory and critical care medicine·2005

Area of Science:

  • Pulmonary Medicine
  • Biomedical Engineering

Background:

  • Surface active material is vital for infant and adult lung function.
  • Surfactant depletion in premature infants necessitates high pressures, leading to hypoxemia and right ventricular dysfunction.
  • Surfactant dysfunction, not depletion, characterizes adult acute lung injury (ALI).

Purpose of the Study:

  • To explore surfactant replacement strategies for respiratory distress syndrome (RDS) in infants.
  • To investigate surfactant delivery methods for acute respiratory distress syndrome (ARDS) in adults.
  • To evaluate the potential of aerosolized surfactant delivery as an alternative to direct instillation.

Main Methods:

  • Review of current surfactant replacement therapies, including direct instillation.
  • Discussion of challenges with current instillation methods, such as fluid bolus effect and distribution issues.

Related Experiment Videos

  • Exploration of aerosol delivery systems for surfactant, focusing on potential for reduced dosage and improved targeting.

    • Main Results:

    • Direct surfactant instillation is effective for infant RDS but has limitations.
    • Aerosol delivery systems are being developed to improve surfactant efficacy and reduce required doses.
    • Targeted delivery of surfactants with associated proteins may be necessary for adult ARDS.

    Conclusions:

    • Aerosolized surfactant delivery presents a promising alternative for both infant RDS and adult ARDS.
    • Further research is needed to validate high-efficiency aerosol systems for surfactant therapy.
    • Optimizing surfactant composition and delivery is key to improving outcomes in lung injury.